Rankin EM[au] - Search Results

Year	Number of Results
1981	1
1982	1
1983	2
1984	4
1985	1
1986	1
1987	7
1988	2
1989	4
1990	3
1991	1
1992	4
1993	6
1994	5
1995	2
1996	3
1998	1
1999	1
2000	1
2002	1
2004	2
2005	2
2006	2
2007	2
2008	2
2009	2
2010	2
2012	1
2022	0

1

Recombinant interleukin-2 in cancer: basic and clinical aspects.

Vlasveld LT, Rankin EM. Vlasveld LT, et al. Among authors: rankin em. Cancer Treat Rev. 1994 Jul;20(3):275-311. doi: 10.1016/0305-7372(94)90004-3. Cancer Treat Rev. 1994. PMID: 8020007 Review. No abstract available.

2

Hypersensitivity reaction to epirubicin.

Cassidy J, Rankin EM. Cassidy J, et al. Among authors: rankin em. Med Oncol Tumor Pharmacother. 1989;6(4):297-8. doi: 10.1007/BF02985165. Med Oncol Tumor Pharmacother. 1989. PMID: 2615533

3

Low back pain and cancer.

Woll PJ, Rankin EM. Woll PJ, et al. Among authors: rankin em. Br Med J (Clin Res Ed). 1987 Nov 14;295(6608):1278. doi: 10.1136/bmj.295.6608.1278. Br Med J (Clin Res Ed). 1987. PMID: 2961405 Free PMC article. No abstract available.

4

Pseudoperipheral palsy due to cortical infarction.

Rankin EM, Rayessa R, Keir SL. Rankin EM, et al. Age Ageing. 2009 Sep;38(5):623-4. doi: 10.1093/ageing/afp025. Epub 2009 Mar 12. Age Ageing. 2009. PMID: 19286678

5

Arterial emboli complicating Cisplatin therapy.

Tait CD, Rankin EM. Tait CD, et al. Among authors: rankin em. Case Rep Oncol Med. 2012;2012:276385. doi: 10.1155/2012/276385. Epub 2012 Feb 28. Case Rep Oncol Med. 2012. PMID: 22606452 Free PMC article.

6

Ophthalmic toxicity during carboplatin therapy.

Rankin EM, Pitts JF. Rankin EM, et al. Ann Oncol. 1993 Apr;4(4):337-8. doi: 10.1093/oxfordjournals.annonc.a058497. Ann Oncol. 1993. PMID: 8518227 Free article. No abstract available.

7

In silico prediction of drug binding to CYP2D6: identification of a new metabolite of metoclopramide.

Yu J, Paine MJ, Maréchal JD, Kemp CA, Ward CJ, Brown S, Sutcliffe MJ, Roberts GC, Rankin EM, Wolf CR. Yu J, et al. Among authors: rankin em. Drug Metab Dispos. 2006 Aug;34(8):1386-92. doi: 10.1124/dmd.106.009852. Epub 2006 May 12. Drug Metab Dispos. 2006. PMID: 16698891

8

Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer.

Verborg WA, Campbell LR, Highley MS, Rankin EM. Verborg WA, et al. Among authors: rankin em. Int J Gynecol Cancer. 2008 Mar-Apr;18(2):228-34. doi: 10.1111/j.1525-1438.2007.00994.x. Epub 2007 May 19. Int J Gynecol Cancer. 2008. PMID: 17511798

9

A mathematical model of the development of drug resistance to cancer chemotherapy.

Birkhead BG, Rankin EM, Gallivan S, Dones L, Rubens RD. Birkhead BG, et al. Among authors: rankin em. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1421-7. doi: 10.1016/0277-5379(87)90133-7. Eur J Cancer Clin Oncol. 1987. PMID: 3678329

10

Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.

Bramwell VH, Howell A, Anderson H, Rankin EM. Bramwell VH, et al. Among authors: rankin em. Clin Oncol. 1983 Sep;9(3):251-6. Clin Oncol. 1983. PMID: 6617000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results